The successful use of lipid bilayer model membranes as targets for cytotoxic lymphocytes is described.
marker were inserted into the lipid vesicles. Incubation of the reconstituted vesicles with lymphocytes sensitized in mixed lymphocyte cultures against allogeneic cells resulted in the specific release of intravesicular 5tCr. Vesicle damage was mediated by thymus-derived lymphocytes. H-2 antigens could be incorporated into vesicles without eye muscle proteins. However, immune damage of the vesicles could not be demonstrated when vesicles inserted with H-2 antigens in the absence of eye muscle proteins were used as targets. Thymus-derived (T) lymphocyte-mediated cytotoxic reactions to alloantigens, virus antigens, minor histocompatibility antigens, and haptens all involve direct or associated recognition of gene products of the major histocompatibility complex (MHC) (1) (2) (3) (4) . Thus, T cell receptors recognize on target cells both MHC and other antigenic ligands. The mechanism whereby T cell reactivity is restricted by target cell MHC phenotype is not yet understood. Model membranes should be useful for the study of allogeneic T cell cytotoxicity as well as the MHC restriction phenomenon, because they involve welldefined systems in which lipid vesicles may be reconstituted with purified MHC gene products in the presence or absence of other cell membrane proteins or exogenous antigens. Although murine MHC components have been incorporated into synthetic liposomes (5) , and reconstituted vesicles have been utilized in the in vitro restimulation of cytotoxic T cells involved in MHC-restricted Sendai virus immunity (6) , such reconstituted vesicles have not yet been reported as targets for cytotoxic T cells.
In a different system designed to study the mechanism of eye muscle injury in human Graves ophthalmopathy, lipid vesicles inserted with human eye muscle membrane proteins (EMP) were damaged when incubated with lymphocytes from patients with Graves ophthalmopathy in the presence of thyroglobulin (Tg) or thyroglobulin-anti thyroglobulin complexes (TgA), whereas lymphocytes from control subjects damaged such vesicles only in the presence of TgA (7). Lipid vesicles lacking EMP or containing other tissue proteins in equivalent amounts were not lysed even if TgA complexes were present, indicating that EMP have some characteristic that renders lipid vesicles susceptible to lysis by immune cells.
The first step in our approach of using model membrane systems as targets in cell-mediated cytolytic reactions was therefore the use of lipid vesicles into which both murine cell
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. membrane proteins (containing the MHC H-2 as specific antigen) and human EMP had been inserted. This report describes the successful use of such reconstituted lipid bilayer membranes as targets for cytotoxic T lymphocytes.
MATERIALS AND METHODS Animals, Cells, and Antisera. BALB/c and C57BL/6J mice were used. Rat monoclonal anti-Thy 1.2 (clone H12C8) antibodies were a gift from J. Ledbetter (Stanford University). Fluorescein-labeled rabbit anti-rat immunoglobulin and 125I-labeled rabbit anti-mouse immunoglobulin antibodies were kindly provided by R. Coffman (Stanford University). Anti-H-2Kd and anti-H-2Dd antisera were a generous gift from H. McDevitt (Stanford University). Human eye muscles were obtained post mortem. LSTRA (H-2d) and EL4 (H-2b) tumor cell lines were maintained in ascitic form by intraperitoneal inoculation of BALB/c (H-2d) or C57BL/6J (H-2b) mice, respectively.
Lipids. Dipalmitoyl lecithin, dimyristoyl lecithin, and cholesterol were purchased from Sigma.
Preparation of Membranes. Plasma membranes were prepared from cell homogenates by sucrose density gradient centrifugation (8) . Finely minced eye muscle tissue in 10 mM Tris-HCl buffer, pH 7.4, containing 1 mM EDTA, 5 mM phenylmethylsulfonyl fluoride, and 5% sucrose was homogenized by a Brinkmann Polytron homogenizer.
The homogenate was filtered through four layers of cheese cloth, layered over 41% sucrose in the same buffer, and centrifuged for 2 hr at 95,000 X g in a Beckman SW 27 rotor. Membranes were harvested from the interface of sucrose solution and the homogenate and pelleted by centrifugation at 105,000 X g for 20 min. After two washes by centrifugation and resuspension, the pellets were stored under liquid nitrogen or at -20°C until used. LSTRA Preparation of Vesicles. Vesicles were prepared by modification of the method described earlier (10) . Ten milligrams of dipalmitoyl lecithin, 5 mg of dimyristoyl lecithin, and 3 mg of cholesterol were dissolved in a 2:1 (vol/vol) mixture of chloroform/methanol. The mixture was dried by rotary evaporation at 50'C and the lipid film was suspended in 2 ml of Pi/NaCl, pH 7.4. The lipid dispersion was kept under argon or nitrogen and sonicated to optical clarity (30-60 min) at 450C with a probe sonicator (microtip, Bronwill-Biosonik, power setting 3). LSTRA or EL4 membrane proteins (5 mg) mixed with eye muscle membrane proteins (5 mg) were treated with 1% sodium deoxycholate and mixed with the sonicated lipid vesicles (lipid-to-protein weight ratio was 2:1). Reconstituted membrane vesicles were obtained by the discontinuous sucrose density gradient centrifugation procedure described above for isolation of membrane proteins, dialyzed against Pi/NaCl, pH 7.4, and pelleted by centrifugation at 10,000 X g for 20 min.
The pellet was resuspended in 1 ml of Pi/NaCl, pH 7.4, containing 1 mCi (1 Ci = 3.7 X 1010 becquerels) of Na5ICrO4 and sonicated in a water bath for 10 min in a closed tube under argon or nitrogen. The sonicated suspension was incubated with the Na5lCrO4 overnight at room temperature, then dialyzed against Pi/NaCl, pH 7.4. to remove free chromate. During the last hour before assay, vesicles were dialyzed against RPMI 1640 medium, then counted in a hemocytometer chamber and diluted to the concentration of 106/ml. The size of vesicles obtained by this method was approximately 1-2 ,um.
The protein content of the vesicles was determined by the method of Lowry et al. (9), phospholipids were estimated by phosphate assay (11) , and cholesterol was measured by using the cholesterol kit from Abbott. The protein content of the vesicles was determined to be 60 + 5% (wt/wt) and cholesterol content was 30 mol%.
Generation of Effector Cells. Spleen cells (2 X 107) were cultured in 5 ml of RPMI 1640 medium + 15% fetal calf serum (FCS) with 2 X 107 mitomycin C-treated stimulator spleen cells (mitomycin C added at 40 ,ug/ml for 1 hr). After 4 days in culture, cells were harvested and tested for cytolytic activity. Control lymphocytes were cultured under the same conditions in the absence of stimulator spleen cells.
51Cr Release Assay. To measure vesicle lysis, 1 X 105 vesicles were mixed in a dialysis bag with lymphoid cells at a final volume of 0.2 ml of RPMI + 15% FCS. The dialysis bags were placed in large tubes containing 12 ml of the same medium and incubated at 37°C. At various intervals, 1-ml aliquots of dialysate were removed. At the end of the experiment the radioactivities of the dialysis bag and the dialysate samples were measured and appropriate corrections were made for volume change. Percentage of specific lysis was calculated as follows: 5tCr release in test -51Cr release in control 51Cr release by Nonidet P-40 (complete lysis) -5ICr release in control
Radioimmunoassay for H-2 Antigens in Vesicles. Vesicles (50 ,ug of protein in 0.05 ml of Dulbecco's modified Pi/NaCl)
were incubated overnight at 4°C in U-bottomed microtiter plates. The plates were washed and incubated for 1 hr with Dulbecco's modified Pi/NaCl + 5% FCS. Mouse anti-H-2 antibodies were added for 1 hr at 4°C. The plates were washed again and '25I-labeled rabbit anti-mouse immunoglobulin antibodies were added for 1 hr at 4°C. The plates were washed and dried and the U-shaped bottoms of the wells were cut off by a hot wire and assayed for 125I activity. RESULTS C57BL (H-2b) spleen cells unsensitized or sensitized to BALB/c spleen cells (H-2d) were incubated with i X 105 vesicles into which EMP + LSTRA (H-2d) cell membrane proteins had been inserted. 5ICr release was determined at different time points. As shown in Fig. 1, 5ICr release, mediated by sensitized lymphocytes, could be demonstrated within 3-hr incubation at relatively low effector cell-to-target vesicle ratios (20:1, 5:1). Higher (100:1) or lower (1:1) lymphocyte-to-vesicle ratios were less effective in damaging vesicles. We therefore routinely carried out the cytolytic assays with effector cell-to-vesicle ratios of 20:1 and 5:1 and determined 51Cr release at 3 hr and 6 hr.
We Time, hr FIG. 1. Vesicle lysis by allosensitized lymphocytes. C57BL/6J lymphocytes (5 X 105 or 2 X 106) sensitized in mixed lymphocyte cultures to BALB/c spleen cells (-, 0) or unsensitized control lymphocytes, cultured under the same conditions in the absence of sensitizing spleen cells (A, 0), were put in dialysis tubing in 100 ,ul of RPMI + 15% FCS. 51Cr-labeled vesicles (1 x 105) reconstituted with EMP and LSTRA membrane proteins were added in 100 ,u1. Ratios of lymphocytes to vesicles are given in the figure. The tubing was placed in a tube containing 12 ml of medium and incubated at 37°C. Samples (1 ml) of dialysate were withdrawn at intervals for measurement of radioactivity.
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Immunology: Hollander et al. (13) . Following the successful use of hapten-bearing model lipid membranes as targets for specific antibodies and complement (14, 15) , there is increasing interest in using lipid vesicles to study other effector functions of the immune system, in particular cell-mediated cytotoxicity. The application of model lipid membranes reconstituted with MHC products may facilitate studies on the molecular basis of MHC-dependent immune reactions and on mechanisms of cell-mediated cytotoxicity, because vesicles with well-defined physical and chemical properties can be constructed from selected lipids and glycoproteins or other membrane components. MHC antigen in the liposome bilayer has been reported to resemble that in the cell membrane with respect to integral insertion, orientation, and retention of serological antibody-binding activity (5) . It has also been reported to induce secondary immune responses (6, 16 of the radionuclide marker within 1-2 hr (unpublished data).
(iii) Protein-to-lipid ratio. The optimal ratio was found to be about 60% protein to 40% lipid (wt/wt). Vesicles containing less than 40% protein were not damaged by immune lymphocytes. To obtain such high protein concentrations, vesicles were prepared by mixing proteins and lipids at a ratio of 1:2, which is 10-fold or more higher than the ratio previously reported (5, 16) . The requirement of 50-60% protein content in breakable vesicles does not imply that the protein fraction should consist exclusively of the antigenic molecules. It is suggested that only part of the protein should represent the specific antigenic moiety, whereas a large proportion can consist of unrelated proteins, such as EMP and other cell membrane proteins. This may be important when vesicles with highly purified antigens, not available in large amounts, are prepared.
The high protein content may also account for the low spontaneous radionuclide release we observed in our vesicle preparation, as opposed to the high background release in other vesicle systems (17) . The diffusion of small molecules has been reported for proteoliposomes (18, 19) and attributed to the displacement of lipid by hydrophobic protein. Indeed, we noticed a high background release of radionuclide in vesicle preparations with low protein content; however, the background release decreased with the increase of protein content and reached low levels (5-10% in 3-6 hr) for vesicles containing 60% protein.
It should be stressed that the system described in this report is not uniformly reproducible. Although the same protocol for vesicle preparation was followed in each case, some experiments resulted in zero or low cytolytic levels as opposed to other experiments resulting in high levels of specific vesicle lysis. The reason for the inconsistency is not clear. Human eye muscles obtained from autopsy are a major variable in the system, and thus may be responsible for the variability observed. Factors such as donor age, drug or other medical treatment, and disease of the eye muscle donor may influence the results. It is also likely that eye muscles must be obtained in a fashion that precludes autolysis, a requirement that is not always feasible to satisfy. It would therefore be an advantage if tissue of species other than human could be used, so that fresh tissue from healthy donors, excised very soon after death and delivered at scheduled times, can be immediately processed and used for vesicle preparation. Preliminary experiments indicate that freshly excised bovine eye muscles can substitute for human tissue, as was demonstrated in previous experiments using EMP vesicles (7) .
Other significant variables in the system are unpredictable contamination of the vesicles with titanium released from the ultrasonic probe, absorption of water by stock phospholipids, and possible copurification of an inhibitor of vesicle lysis in preparing EMP.
In spite of the above-mentioned difficulties, the use of these reconstituted model membranes as targets for cytotoxic lymphocytes may elucidate the molecular basis of MHC-dependent phenomena and the mechanisms of lymphocyte-mediated cytolysis.
